ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Vaccine Drugs Development Services Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-0M18762
Home | Market Reports | Law & Government| Public Safety
Global mRNA Vaccine Drugs Development Services Market Research Report 2024
BUY CHAPTERS

Global mRNA Vaccine Drugs Development Services Market Research Report 2026

Code: QYRE-Auto-0M18762
Report
2026-02-10
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ReciBioPharm
Merck
Samsung Biologics
Thermo Fisher Scientific
Lonza
Ricoh Group
Aldevron
Wuxi Biologics
GenScript ProBio
Novoprotein
Porton Advanced Solutions
Precision Nanosystems

mRNA Vaccine Drugs Development Services Market

The global mRNA Vaccine Drugs Development Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
mRNA vaccine drug development services refer to providing comprehensive and professional technical support and services for the research, development and production of mRNA vaccines. This kind of service covers the research and development and design of mRNA vaccines, production process optimization, quality control, preclinical and clinical research and other aspects. By using advanced mRNA technology and platform-based production processes, we can quickly respond to the threats of various infectious diseases and develop efficient and safe mRNA vaccines. At the same time, the mRNA vaccine drug development service also has strong data analysis capabilities and clinical trial experience, which can provide scientific basis and decision-making support for vaccine research and development. This kind of service is widely used in the field of public health and is of great significance to protecting human health and promoting social development.
The North American market for mRNA Vaccine Drugs Development Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for mRNA Vaccine Drugs Development Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for mRNA Vaccine Drugs Development Services in Non-Replicating mRNA Vaccine Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of mRNA Vaccine Drugs Development Services include ReciBioPharm, Merck, Samsung Biologics, Thermo Fisher Scientific, Lonza, Ricoh Group, Aldevron, Wuxi Biologics, Genscript Probio, Novoprotein, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global mRNA Vaccine Drugs Development Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Vaccine Drugs Development Services. The mRNA Vaccine Drugs Development Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global mRNA Vaccine Drugs Development Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist mRNA Vaccine Drugs Development Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of mRNA Vaccine Drugs Development Services Market Report

Report Metric Details
Report Name mRNA Vaccine Drugs Development Services Market
Segment by Type
  • mRNA Process Development Services
  • mRNA Synthesis Services
  • mRNA Drug Substance Purification Services
  • Others
Segment by Application
  • Non-Replicating mRNA Vaccine Drugs
  • Self-Amplifying mRNA Vaccine Drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ReciBioPharm, Merck, Samsung Biologics, Thermo Fisher Scientific, Lonza, Ricoh Group, Aldevron, Wuxi Biologics, Genscript Probio, Novoprotein, Porton Advanced Solutions, Precision NanoSystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for mRNA Vaccine Drugs Development Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the mRNA Vaccine Drugs Development Services Market report?

Ans: The main players in the mRNA Vaccine Drugs Development Services Market are ReciBioPharm, Merck, Samsung Biologics, Thermo Fisher Scientific, Lonza, Ricoh Group, Aldevron, Wuxi Biologics, Genscript Probio, Novoprotein, Porton Advanced Solutions, Precision NanoSystems

What are the Application segmentation covered in the mRNA Vaccine Drugs Development Services Market report?

Ans: The Applications covered in the mRNA Vaccine Drugs Development Services Market report are Non-Replicating mRNA Vaccine Drugs, Self-Amplifying mRNA Vaccine Drugs

What are the Type segmentation covered in the mRNA Vaccine Drugs Development Services Market report?

Ans: The Types covered in the mRNA Vaccine Drugs Development Services Market report are mRNA Process Development Services, mRNA Synthesis Services, mRNA Drug Substance Purification Services, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccine Drugs Development Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 mRNA Process Development Services
1.2.3 mRNA Synthesis Services
1.2.4 mRNA Drug Substance Purification Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global mRNA Vaccine Drugs Development Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Non-Replicating mRNA Vaccine Drugs
1.3.3 Self-Amplifying mRNA Vaccine Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccine Drugs Development Services Market Perspective (2021–2032)
2.2 Global mRNA Vaccine Drugs Development Services Growth Trends by Region
2.2.1 Global mRNA Vaccine Drugs Development Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 mRNA Vaccine Drugs Development Services Historic Market Size by Region (2021–2026)
2.2.3 mRNA Vaccine Drugs Development Services Forecasted Market Size by Region (2027–2032)
2.3 mRNA Vaccine Drugs Development Services Market Dynamics
2.3.1 mRNA Vaccine Drugs Development Services Industry Trends
2.3.2 mRNA Vaccine Drugs Development Services Market Drivers
2.3.3 mRNA Vaccine Drugs Development Services Market Challenges
2.3.4 mRNA Vaccine Drugs Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccine Drugs Development Services Players by Revenue
3.1.1 Global Top mRNA Vaccine Drugs Development Services Players by Revenue (2021–2026)
3.1.2 Global mRNA Vaccine Drugs Development Services Revenue Market Share by Players (2021–2026)
3.2 Global Top mRNA Vaccine Drugs Development Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by mRNA Vaccine Drugs Development Services Revenue
3.4 Global mRNA Vaccine Drugs Development Services Market Concentration Ratio
3.4.1 Global mRNA Vaccine Drugs Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine Drugs Development Services Revenue in 2025
3.5 Global Key Players of mRNA Vaccine Drugs Development Services Head Offices and Areas Served
3.6 Global Key Players of mRNA Vaccine Drugs Development Services, Products and Applications
3.7 Global Key Players of mRNA Vaccine Drugs Development Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 mRNA Vaccine Drugs Development Services Breakdown Data by Type
4.1 Global mRNA Vaccine Drugs Development Services Historic Market Size by Type (2021–2026)
4.2 Global mRNA Vaccine Drugs Development Services Forecasted Market Size by Type (2027–2032)
5 mRNA Vaccine Drugs Development Services Breakdown Data by Application
5.1 Global mRNA Vaccine Drugs Development Services Historic Market Size by Application (2021–2026)
5.2 Global mRNA Vaccine Drugs Development Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America mRNA Vaccine Drugs Development Services Market Size (2021–2032)
6.2 North America mRNA Vaccine Drugs Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America mRNA Vaccine Drugs Development Services Market Size by Country (2021–2026)
6.4 North America mRNA Vaccine Drugs Development Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Vaccine Drugs Development Services Market Size (2021–2032)
7.2 Europe mRNA Vaccine Drugs Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe mRNA Vaccine Drugs Development Services Market Size by Country (2021–2026)
7.4 Europe mRNA Vaccine Drugs Development Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccine Drugs Development Services Market Size (2021–2032)
8.2 Asia-Pacific mRNA Vaccine Drugs Development Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific mRNA Vaccine Drugs Development Services Market Size by Region (2021–2026)
8.4 Asia-Pacific mRNA Vaccine Drugs Development Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America mRNA Vaccine Drugs Development Services Market Size (2021–2032)
9.2 Latin America mRNA Vaccine Drugs Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America mRNA Vaccine Drugs Development Services Market Size by Country (2021–2026)
9.4 Latin America mRNA Vaccine Drugs Development Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccine Drugs Development Services Market Size (2021–2032)
10.2 Middle East & Africa mRNA Vaccine Drugs Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa mRNA Vaccine Drugs Development Services Market Size by Country (2021–2026)
10.4 Middle East & Africa mRNA Vaccine Drugs Development Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ReciBioPharm
11.1.1 ReciBioPharm Company Details
11.1.2 ReciBioPharm Business Overview
11.1.3 ReciBioPharm mRNA Vaccine Drugs Development Services Introduction
11.1.4 ReciBioPharm Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.1.5 ReciBioPharm Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck mRNA Vaccine Drugs Development Services Introduction
11.2.4 Merck Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.2.5 Merck Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics mRNA Vaccine Drugs Development Services Introduction
11.3.4 Samsung Biologics Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.3.5 Samsung Biologics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific mRNA Vaccine Drugs Development Services Introduction
11.4.4 Thermo Fisher Scientific Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza mRNA Vaccine Drugs Development Services Introduction
11.5.4 Lonza Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.5.5 Lonza Recent Development
11.6 Ricoh Group
11.6.1 Ricoh Group Company Details
11.6.2 Ricoh Group Business Overview
11.6.3 Ricoh Group mRNA Vaccine Drugs Development Services Introduction
11.6.4 Ricoh Group Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.6.5 Ricoh Group Recent Development
11.7 Aldevron
11.7.1 Aldevron Company Details
11.7.2 Aldevron Business Overview
11.7.3 Aldevron mRNA Vaccine Drugs Development Services Introduction
11.7.4 Aldevron Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.7.5 Aldevron Recent Development
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Details
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics mRNA Vaccine Drugs Development Services Introduction
11.8.4 Wuxi Biologics Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.8.5 Wuxi Biologics Recent Development
11.9 Genscript Probio
11.9.1 Genscript Probio Company Details
11.9.2 Genscript Probio Business Overview
11.9.3 Genscript Probio mRNA Vaccine Drugs Development Services Introduction
11.9.4 Genscript Probio Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.9.5 Genscript Probio Recent Development
11.10 Novoprotein
11.10.1 Novoprotein Company Details
11.10.2 Novoprotein Business Overview
11.10.3 Novoprotein mRNA Vaccine Drugs Development Services Introduction
11.10.4 Novoprotein Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.10.5 Novoprotein Recent Development
11.11 Porton Advanced Solutions
11.11.1 Porton Advanced Solutions Company Details
11.11.2 Porton Advanced Solutions Business Overview
11.11.3 Porton Advanced Solutions mRNA Vaccine Drugs Development Services Introduction
11.11.4 Porton Advanced Solutions Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.11.5 Porton Advanced Solutions Recent Development
11.12 Precision NanoSystems
11.12.1 Precision NanoSystems Company Details
11.12.2 Precision NanoSystems Business Overview
11.12.3 Precision NanoSystems mRNA Vaccine Drugs Development Services Introduction
11.12.4 Precision NanoSystems Revenue in mRNA Vaccine Drugs Development Services Business (2021–2026)
11.12.5 Precision NanoSystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ReciBioPharm
Merck
Samsung Biologics
Thermo Fisher Scientific
Lonza
Ricoh Group
Aldevron
Wuxi Biologics
GenScript ProBio
Novoprotein
Porton Advanced Solutions
Precision Nanosystems
List of Tables
 Table 1. Global mRNA Vaccine Drugs Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of mRNA Process Development Services
 Table 3. Key Players of mRNA Synthesis Services
 Table 4. Key Players of mRNA Drug Substance Purification Services
 Table 5. Key Players of Others
 Table 6. Global mRNA Vaccine Drugs Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global mRNA Vaccine Drugs Development Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global mRNA Vaccine Drugs Development Services Market Size by Region (US$ Million), 2021–2026
 Table 9. Global mRNA Vaccine Drugs Development Services Market Share by Region (2021–2026)
 Table 10. Global mRNA Vaccine Drugs Development Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global mRNA Vaccine Drugs Development Services Market Share by Region (2027–2032)
 Table 12. mRNA Vaccine Drugs Development Services Market Trends
 Table 13. mRNA Vaccine Drugs Development Services Market Drivers
 Table 14. mRNA Vaccine Drugs Development Services Market Challenges
 Table 15. mRNA Vaccine Drugs Development Services Market Restraints
 Table 16. Global mRNA Vaccine Drugs Development Services Revenue by Players (US$ Million), 2021–2026
 Table 17. Global mRNA Vaccine Drugs Development Services Market Share by Players (2021–2026)
 Table 18. Global Top mRNA Vaccine Drugs Development Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on mRNA Vaccine Drugs Development Services Revenue, 2025
 Table 19. Ranking of Global Top mRNA Vaccine Drugs Development Services Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by mRNA Vaccine Drugs Development Services Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of mRNA Vaccine Drugs Development Services, Headquarters and Area Served
 Table 22. Global Key Players of mRNA Vaccine Drugs Development Services, Products and Applications
 Table 23. Global Key Players of mRNA Vaccine Drugs Development Services, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global mRNA Vaccine Drugs Development Services Market Size by Type (US$ Million), 2021–2026
 Table 26. Global mRNA Vaccine Drugs Development Services Revenue Market Share by Type (2021–2026)
 Table 27. Global mRNA Vaccine Drugs Development Services Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global mRNA Vaccine Drugs Development Services Revenue Market Share by Type (2027–2032)
 Table 29. Global mRNA Vaccine Drugs Development Services Market Size by Application (US$ Million), 2021–2026
 Table 30. Global mRNA Vaccine Drugs Development Services Revenue Market Share by Application (2021–2026)
 Table 31. Global mRNA Vaccine Drugs Development Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global mRNA Vaccine Drugs Development Services Revenue Market Share by Application (2027–2032)
 Table 33. North America mRNA Vaccine Drugs Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2021–2026
 Table 35. North America mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe mRNA Vaccine Drugs Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific mRNA Vaccine Drugs Development Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific mRNA Vaccine Drugs Development Services Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific mRNA Vaccine Drugs Development Services Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America mRNA Vaccine Drugs Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa mRNA Vaccine Drugs Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa mRNA Vaccine Drugs Development Services Market Size by Country (US$ Million), 2027–2032
 Table 48. ReciBioPharm Company Details
 Table 49. ReciBioPharm Business Overview
 Table 50. ReciBioPharm mRNA Vaccine Drugs Development Services Product
 Table 51. ReciBioPharm Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 52. ReciBioPharm Recent Development
 Table 53. Merck Company Details
 Table 54. Merck Business Overview
 Table 55. Merck mRNA Vaccine Drugs Development Services Product
 Table 56. Merck Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 57. Merck Recent Development
 Table 58. Samsung Biologics Company Details
 Table 59. Samsung Biologics Business Overview
 Table 60. Samsung Biologics mRNA Vaccine Drugs Development Services Product
 Table 61. Samsung Biologics Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 62. Samsung Biologics Recent Development
 Table 63. Thermo Fisher Scientific Company Details
 Table 64. Thermo Fisher Scientific Business Overview
 Table 65. Thermo Fisher Scientific mRNA Vaccine Drugs Development Services Product
 Table 66. Thermo Fisher Scientific Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 67. Thermo Fisher Scientific Recent Development
 Table 68. Lonza Company Details
 Table 69. Lonza Business Overview
 Table 70. Lonza mRNA Vaccine Drugs Development Services Product
 Table 71. Lonza Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 72. Lonza Recent Development
 Table 73. Ricoh Group Company Details
 Table 74. Ricoh Group Business Overview
 Table 75. Ricoh Group mRNA Vaccine Drugs Development Services Product
 Table 76. Ricoh Group Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 77. Ricoh Group Recent Development
 Table 78. Aldevron Company Details
 Table 79. Aldevron Business Overview
 Table 80. Aldevron mRNA Vaccine Drugs Development Services Product
 Table 81. Aldevron Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 82. Aldevron Recent Development
 Table 83. Wuxi Biologics Company Details
 Table 84. Wuxi Biologics Business Overview
 Table 85. Wuxi Biologics mRNA Vaccine Drugs Development Services Product
 Table 86. Wuxi Biologics Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 87. Wuxi Biologics Recent Development
 Table 88. Genscript Probio Company Details
 Table 89. Genscript Probio Business Overview
 Table 90. Genscript Probio mRNA Vaccine Drugs Development Services Product
 Table 91. Genscript Probio Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 92. Genscript Probio Recent Development
 Table 93. Novoprotein Company Details
 Table 94. Novoprotein Business Overview
 Table 95. Novoprotein mRNA Vaccine Drugs Development Services Product
 Table 96. Novoprotein Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 97. Novoprotein Recent Development
 Table 98. Porton Advanced Solutions Company Details
 Table 99. Porton Advanced Solutions Business Overview
 Table 100. Porton Advanced Solutions mRNA Vaccine Drugs Development Services Product
 Table 101. Porton Advanced Solutions Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 102. Porton Advanced Solutions Recent Development
 Table 103. Precision NanoSystems Company Details
 Table 104. Precision NanoSystems Business Overview
 Table 105. Precision NanoSystems mRNA Vaccine Drugs Development Services Product
 Table 106. Precision NanoSystems Revenue in mRNA Vaccine Drugs Development Services Business (US$ Million), 2021–2026
 Table 107. Precision NanoSystems Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. mRNA Vaccine Drugs Development Services Picture
 Figure 2. Global mRNA Vaccine Drugs Development Services Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global mRNA Vaccine Drugs Development Services Market Share by Type: 2025 vs 2032
 Figure 4. mRNA Process Development Services Features
 Figure 5. mRNA Synthesis Services Features
 Figure 6. mRNA Drug Substance Purification Services Features
 Figure 7. Others Features
 Figure 8. Global mRNA Vaccine Drugs Development Services Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global mRNA Vaccine Drugs Development Services Market Share by Application: 2025 vs 2032
 Figure 10. Non-Replicating mRNA Vaccine Drugs Case Studies
 Figure 11. Self-Amplifying mRNA Vaccine Drugs Case Studies
 Figure 12. mRNA Vaccine Drugs Development Services Report Years Considered
 Figure 13. Global mRNA Vaccine Drugs Development Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global mRNA Vaccine Drugs Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global mRNA Vaccine Drugs Development Services Market Share by Region: 2025 vs 2032
 Figure 16. Global mRNA Vaccine Drugs Development Services Market Share by Players in 2025
 Figure 17. Global mRNA Vaccine Drugs Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by mRNA Vaccine Drugs Development Services Revenue in 2025
 Figure 19. North America mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America mRNA Vaccine Drugs Development Services Market Share by Country (2021–2032)
 Figure 21. United States mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe mRNA Vaccine Drugs Development Services Market Share by Country (2021–2032)
 Figure 25. Germany mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific mRNA Vaccine Drugs Development Services Market Share by Region (2021–2032)
 Figure 33. China mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America mRNA Vaccine Drugs Development Services Market Share by Country (2021–2032)
 Figure 41. Mexico mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa mRNA Vaccine Drugs Development Services Market Share by Country (2021–2032)
 Figure 45. Israel mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE mRNA Vaccine Drugs Development Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. ReciBioPharm Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 49. Merck Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 50. Samsung Biologics Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 52. Lonza Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 53. Ricoh Group Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 54. Aldevron Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 55. Wuxi Biologics Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 56. Genscript Probio Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 57. Novoprotein Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 58. Porton Advanced Solutions Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 59. Precision NanoSystems Revenue Growth Rate in mRNA Vaccine Drugs Development Services Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global mRNA Development and Manufacturing Services Market Research Report 2025
Global Vaccine Development Service Market Research Report 2025
Global mRNA CDMO Service Market Research Report 2024
Global mRNA Vaccines and mRNA Drugs Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global Generic Drug Research and Development Services Market Research Report 2024
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Development and Manufacturing Services Market Research Report 2025
Global IVT mRNA Synthesis Service Market Research Report 2025
Global mRNA Treatment Market Research Report 2024
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Therapy Market Research Report 2024
Global mRNA Synthesis Service Market Research Report 2024
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global Antibody Discovery and Development Services Market Research Report 2024
Global Antibody Development Services Market Research Report 2025
Global Nanomedicine Development and Manufacturing Services Market Research Report 2025
Global mRNA Vaccine Raw Materials Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions